{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":1320,"summary":"Hosted by Corey with the Story. Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe! The Daily News Now! — Every city. Every story. AI-powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T18:18:57.837082+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Is AdaptHealth a Buy or Risk","slug":"is-adapthealth-a-buy-or-risk","published_at":"2026-06-11T12:00:40+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/is-adapthealth-a-buy-or-risk","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/529be97f-f088-45f9-8d69-94f44f8822cb.mp3","audio_url":"https://api.fastcast.ai/audio/529be97f-f088-45f9-8d69-94f44f8822cb.mp3","summary":"AdaptHealth’s stock has stalled near $9.94, lagging behind the S&P 500, as flatlining revenue growth, declining profitability, and dismal capital efficiency raise serious concerns. Despite rising revenue, earnings per share have dropped 12.4% annually over five years, and returns on invested capital hover at just 0.3%—worse than the cost of capital. While not a total write-off, the fundamentals suggest significant risk, prompting analysts to steer investors toward stronger alternatives like dominant software firms. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/25c7b61438a62caa","meta_description":"AdaptHealth’s stock has stalled near $9.94, lagging behind the S&P 500, as flatlining revenue growth, declining profitability, and dismal capital effi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":111,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/is-adapthealth-a-buy-or-risk/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/is-adapthealth-a-buy-or-risk.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}